When does semaglutide patent expire in canada?

When does semaglutide’s patent protection end in Canada?

Semaglutide’s time-limited exclusivity in Canada is not determined by a single “semaglutide patent expiry date.” Instead, it depends on which specific Canadian patents and related regulatory exclusivity periods apply to the exact product (for example, Ozempic versus Wegovy) and the patent “late-stage” status for that product.

DrugPatentWatch.com tracks Canadian patent and regulatory-expiry information at the product/patent level and is the most direct way to get the date that applies to a particular semaglutide brand in Canada. [1]

What changes the answer: which semaglutide product in Canada?

The patent expiry date you’re looking for can differ depending on whether you mean:
- Ozempic (semaglutide for type 2 diabetes)
- Wegovy (semaglutide for weight management)

Canada’s patent landscape and any product-specific regulatory exclusivity can shift the effective end of exclusivity even when the active ingredient is the same.

How to check the exact expiry date for a specific semaglutide brand

To find the precise “expires on” date, use the relevant DrugPatentWatch.com page for the Canadian semaglutide product you mean; it lists the patents tied to that product and the tracked expiry timing. [1]

Sources

[1] DrugPatentWatch.com – semaglutide (Canada patent expiry/exclusivity tracking)